Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors [Phase 1]
Phase I study evaluating safety, pharmacokinetics, and preliminary anti-tumor activity of evofosfamide (TH-302) in patients with advanced so…
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study of ARQ 197 in adults with advanced solid tumors provides safety, dose-escalation, and preliminary anti-tumor activity data f…
-
CLINICAL_TRIALS research · 2012-07-19Clinical Trial Update: Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas [Phase 1]
This is a Phase I clinical trial update of oral darinaparsin (ZIO-101-C) in patients with advanced solid tumors and Non-Hodgkin lymphoma; no…
-
CLINICAL_TRIALS withdrawal · 2012-07-11Clinical Trial Update: KRN7000 in Treating Patients With Solid Tumors [Phase 1]
A Phase 1 trial investigating KRN7000 for solid tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: An Open-Label, Dose-Escalation Study of AZD2461 [Phase 1]
Open-label, dose-escalation Phase 1 trial of AZD2461 in patients with refractory solid tumors has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas [Phase 1]
A Phase 1 safety study of SNX-5422 for solid tumor malignancies and lymphoid cancers has been completed.
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial update indicates the study evaluating DX-8951f in children with advanced solid tumors or lymphomas has completed. The…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010) [Phase 1]
Phase 1 pediatric trial of Karenitecin in patients with refractory or recurrent solid tumors has completed.
-
CLINICAL_TRIALS research · 2012-05-01Clinical Trial Update: A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589 [Phase 1]
A Phase 1 study to determine the absorption, distribution, metabolism, and excretion of LBH589 (panobinostat) in cancer patients with advanc…
-
CLINICAL_TRIALS withdrawal · 2012-04-25Clinical Trial Update: Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) [Phase 1]
Phase 1 extension evaluating patupilone's effect on the pharmacokinetics of midazolam and omeprazole in patients with advanced solid tumors …
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine [Phase 1]
Phase I dose-escalation study of oral SB939 alone or with azacitidine has completed, assessing safety/dosing in solid tumors and hematologic…
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the risk of QT interval prolongation with eribulin mesylate (E7389) in patients with advanced solid tumors; the stu…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. [Phase 1]
Phase 1 study comparing the relative bioavailability of two linifanib formulations in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies [Phase 1]
This update covers a Phase 1 study of satraplatin in combination with capecitabine for advanced solid malignancies, sponsored by Agennix; th…
-
CLINICAL_TRIALS research · 2012-02-15Clinical Trial Update: Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity
A clinical trial update examining how neutrophil extracellular traps formed after chemotherapy may contribute to antitumor activity in pedia…
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors [Phase 1]
Phase I study of intravenous Lipotecan (TLC388 HCl) in patients with advanced solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2012-01-27Clinical Trial Update: A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial studied how radiolabeled eribulin is metabolized and eliminated in patients with advanced solid tumors; results were post…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating CP-868,596 alone and in combination with AG-013736 and docetaxel in patients with solid tumors has been completed.
-
CLINICAL_TRIALS research · 2012-01-13Clinical Trial Update: HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating HLA-haploidentical hematopoietic stem cell transplantation in children and adolescents with acute …
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer [Phase 1]
Phase 1 study evaluating the maximum tolerated dose, safety, and pharmacokinetics of oral paclitaxel in patients with advanced solid tumors;…
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Study of MEDI-547 to Evaluate the Safety, Tolerability, and Biologic Activity of IV Administration in Subjects With Relapsed or Refractory Solid Tumors [Phase 1]
Phase 1 study of MEDI-547 in relapsed or refractory solid tumors was terminated; the update provides information on safety, tolerability, an…
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors [Phase 2]
This Phase 2 study update assesses the safety and effectiveness of Combretastatin A-4 Phosphate in combination with chemotherapy for advance…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 safety study evaluating escalating doses of combretastatin in combination with bevacizumab (Avastin) in patients with advanced sol…
-
CLINICAL_TRIALS trial_result · 2011-10-19Clinical Trial Update: Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies [Phase 1]
Phase 1 dose-escalation study of ARQ 621 in adults with metastatic solid tumors and refractory/relapsed hematologic malignancies has complet…
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: A Study to Evaluate Biomarkers in Patients With Solid Tumors (0000-097)(COMPLETED) [Phase 1]
A Phase 1 trial evaluating biomarkers in patients with solid tumors has completed, with results posted in 2011.